G Genprex, Inc.: management transactions · United States · SEC (Form 4) Browse the full management transaction log of Genprex, Inc., a listed equity based in United States. Shares trade on US US, under the oversight of SEC (Form 4). Market capitalisation: €1.8bn. The latest transaction was reported on 23 December 2025 (Attribution). Among the most active insiders: Berger Mark Stanley. The full history is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Last declaration on 23 December 2025
All Executives22 Thresholds0 Prospectus0 Other0
Declarations 22 total
◆ Chief Medical Officer · Executives · 22 Dec 2025
28,500 shares 0Common Stock SEC:0001437749-25-038735:0
● President, CEO and CFO · Executives · 18 Feb 2025
395 shares @ US$0.41 2.4% of flow Common Stock SEC:0001437749-25-004464:0
● Chief Medical Officer · Executives · 18 Feb 2025
585 shares @ US$0.41 4.1% of flow Common Stock SEC:0001437749-25-004466:0
◆ Director · Executives · 5 Dec 2024
4,750 shares 0Common Stock SEC:0001437749-24-036884:0
◆ Director · Executives · 5 Dec 2024
4,750 shares 0Common Stock SEC:0001437749-24-036886:0
◆ Director · Executives · 5 Dec 2024
4,750 shares 0Common Stock SEC:0001437749-24-036882:0
◆ Chief Medical Officer · Executives · 5 Dec 2024
18,250 shares 0Common Stock SEC:0001437749-24-036878:0
◆ President, CEO and CFO · Executives · 5 Dec 2024
29,375 shares 0Common Stock SEC:0001437749-24-036880:0
● Chief Medical Officer · Executives · 18 Feb 2024
1,319 shares @ US$4.40 95.9% of flow Common Stock SEC:0001437749-24-005062:0
● Chief Financial Officer · Executives · 18 Feb 2024
1,126 shares @ US$4.40 71.0% of flow Common Stock SEC:0001437749-24-005055:0
● Chairman, President and CEO · Executives · 18 Feb 2024
2,642 shares @ US$4.40 37.1% of flow Common Stock SEC:0001437749-24-005058:0
◆ Director · Executives · 27 Jun 2023
123,795 shares 0Common Stock SEC:0001437749-23-018939:0
◆ Director · Executives · 27 Jun 2023
123,795 shares 0Common Stock SEC:0001437749-23-018941:0
◆ Director · Executives · 27 Jun 2023
123,795 shares 0Common Stock SEC:0001437749-23-018943:0
▲ EVP GC Chief Strategy Officer · Executives · 21 Apr 2023
20,000 shares @ US$1.0739 100.0% of flow Common Stock SEC:0001437749-23-010869:0
Ideal exit: 16 Jan 2024 (T+270) ▲ Chairman, President and CEO · Executives · 21 Apr 2023
19,000 shares @ US$1.055 62.9% of flow Common Stock SEC:0001437749-23-010871:0
Ideal exit: 16 Jan 2024 (T+270) ◆ EVP GC Chief Strategy Officer · Executives · 18 Feb 2023
245,000 shares 0Common Stock SEC:0001437749-23-004243:0
◆ President & CEO · Executives · 18 Feb 2023
625,000 shares 0Common Stock SEC:0001437749-23-004235:0
◆ Chief Medical Officer · Executives · 18 Feb 2023
245,000 shares 0Common Stock SEC:0001437749-23-004241:0
◆ Chief Financial Officer · Executives · 18 Feb 2023
245,000 shares 0Common Stock SEC:0001437749-23-004237:0
◆ Chief Mfgr & Tech Officer · Executives · 18 Feb 2023
200,000 shares 0Common Stock SEC:0001437749-23-004239:0
◇ Chief Financial Officer · Executives · 28 Jul 2022
116,973 shares @ US$0.015 26.6% of flow Common Stock SEC:0001437749-22-018277:0